Recombinant EGFR/MMP-2 bi-targeted fusion protein markedly binding to non-small-cell lung carcinoma and exerting potent therapeutic efficacyJian Xu, Yong‐Su Zhen, Shenghua Zhang et al.|Pharmacological Research|2017Cited by 31
Intensive fibrosarcoma-binding capability of the reconstituted analog and its antitumor activityJian Xu, Yong‐Su Zhen, Yue Du et al.|Drug Delivery|2017Cited by 6